MENU
AMGN
AS OF
Feb 3 closing price
Price
$338.59
Change
+$43.16 (+14.61%)
Capitalization
182.32B
84 days until earnings call
Intraday BUY SELL Signals
+Compare
AMGN
Stock ticker: NASDAQ
AS OF
Feb 3 closing price
Price
$338.59
Change
+$43.16 (+14.61%)
Capitalization
182.32B

AMGN Amgen Forecast, Technical & Fundamental Analysis

Amgen is a leader in biotechnology-based human therapeutics... Show more

Industry: #Biotechnology
AMGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for AMGN with price predictions
Feb 02, 2026

AMGN in upward trend: 10-day moving average crossed above 50-day moving average on January 23, 2026

The 10-day moving average for AMGN crossed bullishly above the 50-day moving average on January 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 14, 2026. You may want to consider a long position or call options on AMGN as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMGN just turned positive on January 21, 2026. Looking at past instances where AMGN's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

AMGN moved above its 50-day moving average on January 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 233 cases where AMGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AMGN moved out of overbought territory on January 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where AMGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AMGN broke above its upper Bollinger Band on January 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.939) is normal, around the industry mean (9.533). P/E Ratio (26.186) is within average values for comparable stocks, (24.433). Projected Growth (PEG Ratio) (1.058) is also within normal values, averaging (1.907). Dividend Yield (0.028) settles around the average of (0.025) among similar stocks. P/S Ratio (5.099) is also within normal values, averaging (3.990).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. AMGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AMGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

AMGN is expected to report earnings to fall 8.51% to $5.16 per share on April 29

Amgen AMGN Stock Earnings Reports
Q1'26
Est.
$5.16
Q3'25
Beat
by $0.60
Q2'25
Beat
by $0.76
Q1'25
Beat
by $0.61
Q4'24
Beat
by $0.27
The last earnings report on November 04 showed earnings per share of $5.64, beating the estimate of $5.04. With 4.04M shares outstanding, the current market capitalization sits at 182.32B.
A.I.Advisor
published Dividends

AMGN paid dividends on September 12, 2025

Amgen AMGN Stock Dividends
А dividend of $2.38 per share was paid with a record date of September 12, 2025, and an ex-dividend date of August 22, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of human therapeutic products based on cellular biology

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
One Amgen Center Drive
Phone
+1 805 447-1000
Employees
26700
Web
https://www.amgen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BAIG6.770.49
+7.80%
Leverage Shares 2X Long BBAI Daily ETF
CVSB50.76N/A
N/A
Calvert Ultra-Short Investment Grade ETF
HYSA15.15-0.03
-0.16%
BondBloxx USD High Yld Bd Sect Rot ETF
DFAC40.79-0.18
-0.44%
Dimensional US Core Equity 2 ETF
OUSA59.13-0.28
-0.48%
ALPS O'Shares US Quality Div ETF

AMGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+0.82%
PFE - AMGN
63%
Loosely correlated
+0.83%
ABBV - AMGN
58%
Loosely correlated
+1.18%
BMY - AMGN
58%
Loosely correlated
+1.53%
GSK - AMGN
55%
Loosely correlated
+1.69%
NVS - AMGN
55%
Loosely correlated
+1.59%
More